Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Launches
Pharma
AZ's $80B revenue target 'very much within reach,' CFO says
AZ's oncology chief suggested the PD-L1 inhibitor Imfinzi will likely be the company's largest oncology medicine by sales “in the midterm period.”
Angus Liu
Jan 14, 2026 10:00am
Upside for Insmed after Brinsupri’s first-in-class sales beat
Jan 9, 2026 10:40am
Quvara Medical debuts after group buys Becton Dickinson facility
Dec 4, 2025 9:00am
Sandoz's biosimilar to Biogen's Tysabri hits the US after delay
Nov 17, 2025 11:12am
Cobenfy delivers OK debut year as BMS works to ease nerves
Oct 30, 2025 11:19am
Alnylam's ATTR-CM launch blows past estimates again
Oct 30, 2025 8:00am
